Results for plasma pathogen reduction
-
intercept-usa.com
INTERCEPT Blood System
The INTERCEPT Blood System - pathogen inactivation for platelet and plasma components. INTERCEPT is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may
-
interceptusa.com
INTERCEPT Blood System
The INTERCEPT Blood System - pathogen inactivation for platelet and plasma components. INTERCEPT is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may
-
INTERCEPT Blood System
The INTERCEPT Blood System - pathogen inactivation for platelet and plasma components. INTERCEPT is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may
-
INTERCEPT Blood System
The INTERCEPT Blood System - pathogen inactivation for platelet and plasma components. INTERCEPT is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may
-
ceocfomarketwatch.com
Medicinal Plant Technologies, Aphios Corporation, Biotechnology Companies
CEO Interviews 2014, Trevor P. Castor, Green, Enabling Technology Platforms for Drug Discover, Nanotechnology Drug Delivery And Manufacturing Improvement, pathogen inactivation for viral vaccines and virus-free human plasma and biologics, and the sustaina
2 websites blocked by safe search filter.
